Works matching DE "CANCER chemotherapy"


Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    The Immune Microenvironment in Prostate Cancer: A Comprehensive Review.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 521, doi. 10.1159/000541881
    By:
    • Novysedlak, Rene;
    • Guney, Miray;
    • Al Khouri, Majd;
    • Bartolini, Robin;
    • Koumbas Foley, Lily;
    • Benesova, Iva;
    • Ozaniak, Andrej;
    • Novak, Vojtech;
    • Vesely, Stepan;
    • Pacas, Pavel;
    • Buchler, Tomas;
    • Ozaniak Strizova, Zuzana
    Publication type:
    Article
    11

    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.

    Published in:
    Oncology, 2025, v. 103, n. 6, p. 469, doi. 10.1159/000541544
    By:
    • Nakazawa, Nobuhiro;
    • Sano, Akihiko;
    • Kumakura, Yuji;
    • Yamashita, Toshiki;
    • Tanaka, Naritaka;
    • Saito, Kana;
    • Kimura, Akiharu;
    • Kasuga, Kengo;
    • Nakazato, Kenji;
    • Yoshinari, Daisuke;
    • Shimizu, Hisashi;
    • Ubukata, Yasunari;
    • Hosaka, Hisashi;
    • Shiraishi, Takuya;
    • Sakai, Makoto;
    • Sohda, Makoto;
    • Shirabe, Ken;
    • Saeki, Hiroshi
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Response to Venkataraman and Mokbel Free.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 6, p. 1289, doi. 10.1093/jnci/djaf087
    By:
    • Arecco, Luca;
    • Blondeaux, Eva;
    • Agostinetto, Elisa;
    • Azambuja, Evandro De;
    • Lambertini, Matteo;
    • Mastro, Lucia Del
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32

    The Impact of Prehabilitation on Patient Outcomes in Oesophagogastric Cancer Surgery: Combined Data from Four Prospective Clinical Trials Performed Across the UK and Ireland.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1836, doi. 10.3390/cancers17111836
    By:
    • Barman, Sowrav;
    • Russell, Beth;
    • Walker, Robert C.;
    • Knight, William;
    • Baker, Cara;
    • Kelly, Mark;
    • Gossage, James;
    • Zylstra, Janine;
    • Whyte, Greg;
    • Pate, James;
    • Lagergren, Jesper;
    • Van Hemelrijck, Mieke;
    • Browning, Mike;
    • Allen, Sophie;
    • Preston, Shaun R.;
    • Sultan, Javed;
    • Singh, Pritam;
    • Rockall, Timothy;
    • Robb, William B.;
    • Tully, Roisin
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1744, doi. 10.3390/cancers17111744
    By:
    • Lema, Laura;
    • Pérez-García, José Manuel;
    • Blanch, Salvador;
    • Balmaña, Judith;
    • García-Sáenz, José Ángel;
    • Vegas, Elena Filipovich;
    • Jiménez, Begoña;
    • de la Haba, Juan;
    • Campolier, Marta;
    • Shimizu, Eileen;
    • Alcalá-López, Daniel;
    • Sampayo-Cordero, Miguel;
    • Cortés, Javier;
    • Llombart-Cussac, Antonio
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50